The size of the Defibrillators market in the Asia Pacific was approx. USD 2.13 billion in 2021, and it is estimated to grow at a CAGR of 7.5% to reach USD 3.06 billion by 2026.
A defibrillator is a vital tool in cardiopulmonary resuscitation indicated in cardiac arrhythmia. As per the 2015 report issued by the Institute of Medicine, approximately 600,000 people are victims of cardiac arrest per year in the U.S., with about 65% of cases in out-of-hospital settings. The survival rate of the out-of-hospital environment is below 6%, whereas it is 24% in hospital settings. Inadequate operational knowledge among consumers regarding defibrillators and about carrying out CPR results in a degenerate survival rate in out-of-hospital cardiac arrest cases.
The Asia-Pacific market is considered an emerging market due to CHD, stroke, and other heart conditions. It has grown moderately due to several factors, including rising healthcare costs, improving infrastructure and economics, and increasing living standards. Developing healthcare systems, large-scale CVD, the spread of stroke and heart disease, and private sector investment are expected to drive the market over the next few years.
The defibrillation procedure involves electrical shock to the heart to depolarize the myocardium and restore normal electrical impulses. The increasing focus of public and private sector defibrillators (PADs) on publicly available defibrillators (PADs) is driving the market growth. Besides, advanced defibrillator devices, a rapidly increasing aging population at high risk of target disease, and an increased incidence of heart disease across all age groups are driving the market growth.
Factors such as weak defibrillation policy reimbursement policies, under-equipped medical infrastructure, limited medical and patient awareness of various therapeutic devices, and high device costs challenge the market growth.
This research report segmented and sub-segmented the Asia-Pacific Defibrillators Market into the following categories:
Regionally, it is capturing 20% of the Global Defibrillators Market.
Some of the Prominent Companies leading the Asia-Pacific Defibrillators Market Profiled in the Report are Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), and Nihon Kohden Corporation (Japan)
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Implantable Cardioverter Defibrillators (ICDS)
5.1.2.1 Transvenous Implantable Cardioverter Defibrillators (T-ICDS)
5.1.2.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
5.1.2.1.2 Dual-Chamber ICDS
5.1.2.1.3 Single-Chamber ICDS
5.1.2.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
5.1.3 External Defibrillators
5.1.3.1 Automated External Defibrillators (AEDS)
5.1.3.1.1 Semi-Automated External Defibrillators
5.1.3.1.2 Fully Automated External Defibrillators
5.1.3.2 Manual External Defibrillators
5.1.3.3 Wearable Cardioverter Defibrillators (WCDS)
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 End User
5.2.1 Introduction
5.2.2 Hospitals, Clinics, & Cardiac Centres
5.2.3 Pre-Hospitals
5.2.4 Public Access Markets
5.2.5 Home Care
5.2.6 Alternate Care Markets
5.2.7 Y-o-Y Growth Analysis, By End User
5.2.8 Market Attractiveness Analysis, By End User
5.2.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic PLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 St. Jude Medical, Inc.
8.3 Boston Scientific Corporation
8.4 Philips Healthcare (A Division of Koninklijke Philips N.V.)
8.5 Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
8.6 Biotronik Se & Co.Kg
8.7 Physio-Control International, Inc.
8.8 Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group)
8.9 Sorin Group (Now Livanova PLC)
8.10 Nihon Kohden Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
